Nason Maani holds a Lectureship in Inequalities and Global Health Policy in the School of Social and Political Sciences at the University of Edinburgh. His research focuses on the structural and commercial drivers of health inequalities. He is a Fellow of the Royal Society of the Arts, and an Adjunct Assistant Professor at Boston University School of Public Health. He previously was Assistant Professor at the London School of Hygiene and Tropical Medicine as a member of the UK PRP SPECTRUM Consortium and co-founded the Commercial Determinants Research Group at LSHTM. He was a 2019-2020 Commonwealth Fund Harkness Fellow in Healthcare Policy and Practice.

Mark Petticrew is Professor of Public Health at the London School of Hygiene and Tropical Medicine and Director of the NIHR Public Health Policy Research Unit. His research has a focus on the commercial determinants of health and in particular, the influence of unhealthy commodity industries on health. He is a member of the UK PRP

SPECTRUM Consortium which conducts research on the commercial determinants of health and other topics. His other research has examined alcohol advertising and marketing from a systems perspective and includes analyses of misinformation disseminated by alcohol industry corporate social responsibility bodies. He is a co-founder and member of the Commercial Determinants Research Group at LSHTM.

Sandro Galea is Dean and Robert A. Knox Professor at the Boston University School of Public Health. He has been named an epidemiology innovator by Time, a top voice in healthcare by LinkedIn, and is one of the most cited social scientists in the world. His writing and work are featured regularly in national and global public media. A native of Malta, he has served as a field physician for Doctors Without Borders and has held academic positions at Columbia University, University of Michigan, and the New York Academy of Medicine.

Section 1: Why Commercial Determinants?
Chapter 1: Commercial Determinants of Health: An Introduction
Nason Maani, Mark Petticrew, and Sandro Galea
Chapter 2: A Systems Perspective on the Pathways of Influence between CDOH and Health
Cécile Knai and Natalie Savona
Chapter 3: Global Health and Equity Burden of Commercial Determinants of Health
Julia Anaf, Fran Baum, and Matt Fisher
Section 2: How Do Commercial Determinants Shape Upstream Drivers of Health?
Chapter 4: The Role of Policy in Studying the Commercial Determinants of Health
Benjamin Hawkins
Chapter 5: Understanding the Politics of the Commercial Determinants of Health
Eduardo J. Gómez
Chapter 6: The Role of Commercial Influences in Public Understanding of Harms, Causes and Solutions
Mark Petticrew, Nason Maani, and May van Schalkwyk
Chapter 7: The Role of Corporations in Influencing Culture
Nancy Tomes
Chapter 8: Industry Influence on Science: What Is Happening and What Can Be Done
Alice Fabbri and Anna Gilmore
Chapter 9: Role in Trade Deals and Investment
Pepita Barlow and Eric Crosbie
Section 3: Case Studies by Industry
Chapter 10: Hidden from View: Alcohol Industry Efforts to Keep the Epidemic of Alcohol-Related Harm from Public Awareness
Tim Stockwell and Erin Hobin
Chapter 11: Learning from 70 Years of Tobacco Control: Winning the War and Not Just the Battles
Anna B. Gilmore and Sarah Dance
Chapter 12: The Fossil Fuel Industry: Fuelling Doubt and Navigating Contradiction
May van Schalkwyk, Nason Maani, and Mark Petticrew
Chapter 13: The Gambling Industry: Harmful Products, Predatory Practices and the Politics of Knowledge
May van Schalkwyk and Rebecca Cassidy
Chapter 14: Sugar-Sweetened Beverages
Eric Crosbie, Laura Schmidt, Jim Krieger, and Marion Nestle
Section 4: Cross-Industry Mechanisms
Chapter 15: Marketing
Simone Pettigrew and Alexandra Jones
Chapter 16: Corporate Social Responsibility: Past, Present, and Future
Nino Paichadze, Vinu Ilakkuvan, Muluken Gizaw, and Adnan A. Hyder
Chapter 17: The Institutionalization of Corporate Power within Policy
Gary Fooks
Chapter 18: Corporations as Irresponsible Artificial People: Human Rights, Profits, and Public Health
George J. Annas
Chapter 19: Industry Influence on Research: A Cycle of Bias
Lisa Bero
Chapter 20: The Global Technology Sector as a Commercial Determinant of Health
Nora Kenworthy, Katerini Tagmatarchi Storeng, and Marco Zenone
Section 5: Advancing Science and Scholarship
Chapter 21: Defining the Commercial Determinants of Health
Jennifer Lacy-Nichols, Cassandra de Lacy-Vawdon, and Rob Moodie
Chapter 22: Assessing Power Structures
Joana Madureira Lima
Chapter 23: Rethinking Conflict of Interest: From Individual to Structural Understandings
Jeff Collin, Rob Ralston, and Sarah Hill
Chapter 24: Assessing the Health Impacts of the Commercial Determinants of Health
Luke N. Allen
Chapter 25: Assessing the Economic Impacts of Corporations
Martin McKee
Chapter 26: Prioritizing Research on the Foundational Drivers of Corporate Policy Influence
William H. Wiist
Chapter 27: The Influence of Commercial Industries on Public Discourse
Shona Hilton
Chapter 28: Commercial Determinants of Health in Low- and Middle-Income Countries
Salma M. Abdalla, Leona Ofei, Nason Maani, and Sandro Galea
Section 6: A Way Forward
Chapter 29: The Question of Industry Partnerships
Peter J. Adams
Chapter 30: Understanding and Managing Corporate Conflicts of Interest
Katherine Cullerton and Martin White
Chapter 31: Teaching the Commercial Determinants of Health
Nicholas Freudenberg and Eric Crosbie
Chapter 32: Learning from Experience: Identifying Key Intervention Points around Corporate Practices to Improve Health
Mélissa Mialon, Julia Anaf, and Fran Baum
Chapter 33: A Policy Agenda for the Commercial Determinants of Health
Sally Casswell
Chapter 34: Commercial Determinants of Health: A Research and Translational Agenda
Nason Maani, Mark Petticrew, and Sandro Galea

Index